NEW YORK (GenomeWeb) — Adarza Biosystems said today that it has closed a $5 million Series B funding round.

The company plans to use the proceeds to expand the production capacity of its manufacturing facility in St. Peters, Missouri, and to launch its first immunoassay instrument platform. Adarza also said it will accelerate the development of assays targeting biological analytes, including cytokines, antigens, and small molecules.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.

In Science this week: in vitro generation of human reproductive cells, and more.

Oct
10
Sponsored by
Philips Genomics

This webinar will provide a first-hand look at how the Dana-Farber Cancer Center is adapting its oncology care strategy in light of the rapidly evolving molecular landscape.